7 3 (chemotherapy) - definizione. Che cos'è 7 3 (chemotherapy)
Diclib.com
Dizionario ChatGPT
Inserisci una parola o una frase in qualsiasi lingua 👆
Lingua:     

Traduzione e analisi delle parole tramite l'intelligenza artificiale ChatGPT

In questa pagina puoi ottenere un'analisi dettagliata di una parola o frase, prodotta utilizzando la migliore tecnologia di intelligenza artificiale fino ad oggi:

  • come viene usata la parola
  • frequenza di utilizzo
  • è usato più spesso nel discorso orale o scritto
  • opzioni di traduzione delle parole
  • esempi di utilizzo (varie frasi con traduzione)
  • etimologia

Cosa (chi) è 7 3 (chemotherapy) - definizione

ASPECT OF HISTORY
Combination chemotherapy; History of chemotherapy
  • CML]], inhibited by <em style="color:red;font-style:normal">imatinib</em> (small molecule).
  • alkylating agent]]; [[cyclophosphamide]], a [[nitrogen mustard]]; [[doxorubicin]], an [[anthracycline]]; and [[etoposide]], a [[topoisomerase inhibitor]].
  • [[Sidney Farber]]'s work was instrumental in showing that effective pharmacological treatment of cancer was possible

Matthew 3:7         
VERSE OF THE BIBLE
O generation of vipers; Mt. 3:7
Matthew 3:7 is the seventh verse of the third chapter of the Gospel of Matthew in the New Testament. The verse occurs in the section introducing John the Baptist.
History of cancer chemotherapy         
The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. The targeted therapy revolution has arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers still apply.
Post-chemotherapy cognitive impairment         
IMPAIRMENT THAT CAN RESULT FROM CHEMOTHERAPY TREATMENT
Chemobrain; Chemo brain; Chemo fog; Chemotherapy-induced cognitive dysfunction; Chemofog; Chemotherapy induced cognitive decline; Chemotherapy-induced cognitive decline; Chemotherapy-induced cognitive impairment; CRCI; Chemotherapy-Related Cognitive Impairment
Post-chemotherapy cognitive impairment (PCCI) (also known in the scientific community as "CRCIs or Chemotherapy-Related Cognitive Impairments" and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment. Approximately 20 to 30% of people who undergo chemotherapy experience some level of post-chemotherapy cognitive impairment.

Wikipedia

History of cancer chemotherapy

The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. The targeted therapy revolution has arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers still apply.